Literature DB >> 19602874

Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

Evgeny Klyuchnikov1, Philippe Schafhausen, Nicolaus Kröger, Tim H Brummendorf, Okay Osanmaz, Svetlana Asenova, Tatjana Zabelina, Sunday Ocheni, Francis Ayuk, Axel R Zander, Ulrike Bacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19602874     DOI： 10.1159/000228587

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  7 in total

1.  How I treat childhood CML.

Authors:  Jeffrey R Andolina; Steven M Neudorf; Seth J Corey
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

Review 2.  Allogeneic stem cell transplantation for chronic myeloid leukemia.

Authors:  Jiří Pavlů; Jane F Apperley
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

3.  Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Authors:  Daniel N Egan; Lan Beppu; Jerald P Radich
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

4.  Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Nira Varda-Bloom; Ivetta Danylesko; Roni Shouval; Shiran Eldror; Atar Lev; Jacqueline Davidson; Esther Rosenthal; Yulia Volchek; Noga Shem-Tov; Ronit Yerushalmi; Avichai Shimoni; Raz Somech; Arnon Nagler
Journal:  Oncotarget       Date:  2017-01-03

Review 5.  Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults.

Authors:  Khalil Saleh; Alexis Fernandez; Florence Pasquier
Journal:  Cancers (Basel)       Date:  2022-04-01       Impact factor: 6.639

Review 6.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

7.  Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation.

Authors:  Shokichi Tsukamoto; Satoshi Ota; Chikako Ohwada; Yusuke Takeda; Masahiro Takeuchi; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Leuk Res Rep       Date:  2013-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.